Close
ACHEMA MIDDLE EAST 2026

Hybrid Gene Therapy Approach Shows Promise in Treating Metabolic Diseases

Researchers at the University of Pennsylvania and Children’s National Hospital in Washington, DC utilized a hybrid approach that combined gene therapy with gene editing...

Thermo Fisher Announces Collaboration to Develop Highly Sensitive Analytical Workflow for Infectious Disease Diagnosis and Patient Monitoring

Thermo Fisher Scientific, the world leader in serving science, and NanoPin Technologies, Inc., the developer of the novel NanoPin diagnostic platform for rapid and...

BetterLife Pharma Acquires Solmic AG with Unique Global Patent for Production of New Generation CBD Biopharmaceuticals

BetterLife Pharma Inc announced the acquisition of Swiss based Solmic AG with its strong IP portfolio including unique formulation technology for the production of...

Catalent acquires cell and gene therapy-focused MaSTherCell for $315m

The transaction is expected to be completed in the third quarter of Catalent’s 2020 financial year, and is subject to customary closing conditions. Following...

Avacta and Daewoong Agree Collaboration and License Agreement with AffyXell Therapeutics

Avacta Group plc , the developer of Affimer biotherapeutics and reagents, is pleased to announce that it has signed a collaboration and license agreement...

Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC

Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to...

Eli Lilly to build $470m pharmaceutical manufacturing facility in North Carolina

Eli Lilly is set to invest more than $470m to build a new pharmaceutical manufacturing facility in North Carolina, US. North Carolina Governor Roy Cooper...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...